Glenmark Pharmaceuticals shares issues as India Ratings and Research releases rating rationale
Why did Glenmark Pharmaceuticals Ltd shares jump today?
Glenmark Pharmaceuticals Ltd shares saw a modest increase of 0.28% on Friday, trading at ₹2423.8 at 12:13 PM. The movement was driven by a positive development reported in a regulatory filing by the company.
Glenmark announced that it had received a credit rating reaffirmation from India Ratings and Research. The rating agency reaffirmed the company’s credit rating, indicating continued financial stability and creditworthiness. Such reaffirmations are typically viewed positively by the market as they reduce uncertainty about a company’s debt obligations and financial health.
The reaffirmation of the credit rating likely boosted investor confidence, leading to the slight uptick in the share price. It signals that the company is maintaining a stable financial position, which is a reassuring sign for shareholders and potential investors alike.
What does Glenmark Pharmaceuticals Ltd do?
I cannot provide a description of Glenmark Pharmaceuticals Ltd.'s business as the provided document extract contains no information about the company's activities, sector, or products.
Glenmark Pharmaceuticals Ltd Financials
In CroresGlenmark Pharmaceuticals Ltd showed positive financial performance between March and June 2026. Revenue increased from ₹3760.28 Crores to ₹3931.73 Crores, representing a quarter-over-quarter growth of approximately 4.56%. More significantly, net profit rose sharply from ₹301.41 Crores to ₹482.92 Crores, indicating a substantial growth of about 60.21% in the same period. This trend demonstrates both top-line expansion and a considerable improvement in profitability.
Glenmark Pharmaceuticals Ltd Shareholding Pattern
Promoter holding stands at 46.65% of the total share capital. Foreign Institutional Investors (FIIs) hold 20.89% stake in the company, while Domestic Institutional Investors (DIIs) hold 18.6%. Public shareholders hold the remaining 13.85% stake in Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd FAQs
Q: Why did Glenmark shares jump 0.28% today?
Please find enclosed rating rationale issued by India Ratings and Research. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Glenmark Pharmaceuticals Ltd?
As per the latest data, promoters hold 46.65% stake in Glenmark Pharmaceuticals Ltd, while FII holding stands at 20.89%. Domestic institutional investors hold 18.6%, and public shareholders account for 13.85% of the equity.
Q: What is the current stock price of Glenmark Pharmaceuticals Ltd?
Glenmark Pharmaceuticals Ltd shares are currently trading at ₹2423.8, recording a gain of 0.28% from the previous close.
Q: What is the market capitalization of Glenmark Pharmaceuticals Ltd?
The company currently has a market capitalization of ₹68405.62 crore, reflecting its valuation in the Indian equity market.